October 10, 2011
WHO Warns of Consequences of Underfunding TB
September 11, 2011
Riminophenazines show potential as next-generation TB drugs
May 8, 2011
Stakeholders cite key actions critical to maximize uptake and impact of new TB regimen introductions
May 3, 2011
The private TB drug market, which has irregular practices that could be driving treatment failures and the emergence of drug-resistant tuberculosis, is now shown to be as large as the public market.